Article Sidebar
Views pdf: 328
ANALYSIS OF THE BURDEN OF TYPE 2 DIABETES MELLITUS IN VIETNAM: A MULTI-CENTER STUDY IN SELECTED DISTRICT-LEVEL HOSPITALS IN HO CHI MINH CITY
Main Article Content
Abstract
Objective: This study aimed to evaluate the burden of type 2 diabetes mellitus (T2DM) in district-level hospitals in Vietnam, based on the clinical characteristics of the patients. Methods: A descriptive retrospective cross-sectional study was performed using the medical records of T2DM patients from Le Van Thinh Hospital and District 8 Hospital in Ho Chi Minh City, Vietnam, in 2021. Clinical outcomes were evaluated using the Charlson Comorbidity Index (CCI), Diabetes Complication Severity Index Score (DCSI), and the prevalence of urinary tract infections (UTIs) among T2DM patients. The economical burden of disease was represented by the annual total direct medical cost. Data analyses were conducted using R Statistical Software V.4.2.2 and Power BI Software. Results: The sample comprised 9.792 patients; 93,4% of these had at least one comorbidity. UTIs accounted for 30,4% of all infectious conditions among T2DM patients, and complex conditions were present in 54,0% of the cases. The mean annual direct medical cost per patient was 2.338.662 (±2.434.657) VND. There were significant positive Spearman correlation coefficients for the CCI score, DCSI score, and the frequency of UTIs in T2DM patients. The mean (SD) CCI and DCSI scores for the population were 3,6 (±1,6) and 0,8 (±1,0), respectively. Conclusion: T2DM causes a significant burden in terms of health and economy for the whole society. These findings can contribute to reasonable budget allocation and the development of more effective treatment protocols.
Article Details
Keywords
Burden of Disease, Type 2 Diabetes Mellitus, CCI Score, DCSI Score, Urinary Tract Infections, Ho Chi Minh City, District Level Hospitals, Health Insurance.
References
2. Safiri S, Karamzad N, et al. (2022). Prevalence, deaths and disability-adjusted-life-years (dalys) due to type 2 diabetes and its attributable risk factors in 204 countries and territories, 1990-2019: results from the global burden of disease study 2019. Front Endocrinol (Lausanne). 13: 838027.
3. Nguyễn Thị Thùy Trang, Phạm Ngọc Thủy Tiên, Hoàng Thy Nhạc Vũ (2022). Phân tích chi phí trực tiếp y tế trong điều trị Đái tháo đường type 2 tại Bệnh viện Quận 8 Thành phố Hồ Chí Minh giai đoạn 2019-2021. Tạp Chí Y học Việt Nam. 514(1).
4. Hoàng Thy Nhạc Vũ, Nguyễn Đỗ Hồng Nhung, Lê Phước Thành Nhân, Trần Văn Khanh (2022). Phân tích chi phí trực tiếp y tế trong điều trị Đái tháo đường típ 2 cho người bệnh có Bảo hiểm y tế tại Bệnh viện Lê Văn Thịnh năm 2021. Tạp Chí Y học Việt Nam, 519(1).
5. Nguyễn Thị Anh Thư, Phùng Đức Nhật, Tô Hoàng Linh (2021). Chi phí điều trị nội trú của người bệnh đái tháo đường típ 2 tại Bệnh viện Quận 6 Tp.HCM. Tạp chí Nghiên cứu Y học. 142 (6), tr. 119-125.
6. Tuan Kiet Pham H, Tuyet Mai Kieu T, et al. (2020). Direct medical costs of diabetes and its complications in Vietnam: A national health insurance database study. Diabetes Res Clin Pract. 162: 108051.
7. Park S, Kario K, et al. (2016). Target blood pressure in patients with Diabetes: asian Perspective. Yonsei Med J. 57: 1307–11.
8. Young BA, Lin E, et al. (2008). Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care. 14: 15–23.
9. Meyers JL, Parasuraman S, et al. (2014). The high-cost, type 2 diabetes mellitus patient: an analysis of managed care administrative data. Arch Public Health. 72(1):6.
10. Conwell LJ, Cohen JW (2002). Characteristics of people with high medical expenses in the U.S. civilian noninstitutionalized population. Statistical Brief. 73: 2005.